In industrialized countries newborn infants are being exposed to an increasingly artificial environment, with larger delivery units, an increased use of disinfectants and antibiotics, and a decreased incidence of breast feeding. The fact that this trend has continued side by side with a situation where infections have played a diminishing role in neonatal morbidity and mortality has created the impression that such changes have been beneficial, or at least not harmful, to the infant.
Lately some reports have suggested a changing pattern with an increased frequency of colonization and infection caused by Gram-negative bacteria (McCracken and Shinefield, 1966; Samuel and Gould, 1967; Conn, 1969; British Medical Journal, 1970) . There may be a multifactorial background to such an increase, including some of the factors listed above. The possible role of the low consumption of breast milk has attracted little attention, and historically the fact that the antibodies of milk are not absorbed from the gut in the human (Vahlquist, 1958) (Smith and Crabb, 1961) , which has been ascribed to the fact that young animals of different species are all fed with milk.
In 1905 Tissier found that anaerobic Bacterium bifidum predominated over coliform bacteria in the 845 faecal flora of breast-fed infants, and that this relation was reversed by bottle feeding. The Esch. coli counts never reach as high as 1010 organisms/g faeces in breast-fed infants, whereas in the bottle fed they commonly do so (Bullen and Willis, 1971 ). In addition, faeces from bottle-fed infants grow proteus and Pseudomonas aeruginosa (Bullen and Willis, 1971) . Whether Clostridium welchii and bacteroides appear in the faeces of breast-fed infants is controversial (Smith and Crabb, 1961; Bullen and Willis, 1971) . Bacteria of the Klebsiella cloacae group have been reported to be frequent gastrointestinal colonizers of the neonates in some maternity wards (Gareau et al., 1959) . The throats of breast-fed babies are reported to be less often colonized with Esch. coli than those partly or entirely bottle fed, and Esch. coli contamination of the artificial food seemed not to account for this (McFarlan, Crone, and Tee, 1949) .
It is so far unknown whether the common colonization of the newborn with Candida albicans is related to bottle feeding or not. It has been shown that unsaturated lactoferrin of breast milk inhibits growth of Candida albicans (Kirkpatrick et al., 1971) .
Infections in the Newborn in Relation to Feeding The difference in incidence of enteric infections in breast-fed and in bottle-fed infants is well known. It is hard to judge whether this difference is due to a beneficial effect of breast milk or an increased contamination during bottle feeding. A protective role of breast milk against enteric infections is suggested, however, from several observations. An epidemic among newborns of enterocolitis caused by Esch. coli 0 11 1-B4 remained uncontrolled for 6 months in spite of the use of classical epidemiological measures: administration of unprocessed breast milk to all the newborns was accompanied by a rapid cessation of the epidemic (Tassovatz and Kotsitch, 1961) . Svirsky-Gross (1958) showed a rapid improvement of diarrhoea caused by Esch. coli 0 111 after feeding breast milk. Crosse (1966) states that she has never observed an enteropathogenic Esch. coli (EPEC) infection in a breast-fed newborn. In a recent study among newborns and small infants of a preindustrial society in Guatemala, Mata and Llrrutia (1971) showed that diarrhoea was uncommon in breast-fed infants though exposure to shigella, enteropathogenic Esch. coli, and salmonella was common. Diarrhoea appeared with weaning.
More difficult to evaluate with regard to a beneficial effect of breast milk-though often citedare studies of neonatal shigella infections, showing a low incidence of neonatal shigellosis in countries with endemic shigella infection. Neonatal shigella infection in such environments is said to be very mild (Mata et al., 1969; Floyd, Higgins, and Kader, 1956) , whereas in the western part of the world shigella infections are followed by severe symptoms (Haltalin, 1967; Salzman, Sher, and Moss, 1967) and sometimes septicaemia (Whitfield and Humphries, 1967) . Different habits with regard to breast feeding may account for these reported differences. A similar difference between industrialized and nonindustrialized societies with regard to enteropathogenic Esch. coli was pointed out by Mata and Urrutia (1971) .
Breast milk feeding interferes with oral poliovaccination (Warren et al., 1964) . It has been suggested that breast-fed infants are less prone to respiratory infections and otitis media (Robinson, 1951; von Sydow and Faxen, 1954; Mellander, Vahlqvist, and Mellbin, 1959) , though evaluation of such data is difficult (Stanfield, 1959) . Finally, some indirect evidence suggests that breast milk may protect against septicaemia and meningitis in the newborn (Winberg and Wessner, 1971 (Hanson and Johansson, 1970) . Hitherto these antibodies have been supposed to be of minor importance since they are not absorbed by the gut of the human infant (Vahlquist, 1958; Ammann and Stiehm, 1966) , but this assumption became questioned when it was discovered that IgA was the predominant immunoglobulin in milk in contrast to serum (Gugler et al., 1958; Hanson, 1960 Hanson, , 1961 and that the milk IgA was antigenically different from serum IgA (Hanson, 1961) . Milk IgA forms part of a local defence system consisting of locally produced 'secretory IgA' making up the dominating immunoglobulin in most secretions (Tomasi et al., 1965) . It has been suggested that this secretory immunoglobulin effects an antimicrobial protection of mucous membranes (Tomasi and Bienenstock, 1968) . These facts make it likely that the function of milk antibodies will be locally acting, primarily in the gastrointestinal tract (Hanson and Brandtzaeg, 1972; Gindrat et al., 1972) .
Breast milk contains antibodies against the most important bacterial pathogen of the neonate, Esch. coli (Kenny, Boesman, and Michaels, 1967; Michael, Ringenback, and Hottenstein, 1971; Gindrat et al., 1972) . Recently it was noted that such milk antibodies are directed against Esch. coli of those 0 groups which are commonly found to be causing neonatal infections (Gindrat et al., 1972) . This finding may be relevant to the observation that in a group of neonates with Esch. coli septicaemia or meningitis, the breast milk consumption was lower than in controls (Winberg and Wessner, 1971 ). This observation may be a parallel to that of several authors (e.g. Warren et al., 1964) that breast milk containing polio-antibody prevents successful oral immunization with live polio virus vaccine by neutralizing the virus in the gut.
The Esch. coli antibodies in human milk primarily seem to be of the secretory IgA class (Hodes et al., 1964; Hanson and Johansson, 1970) , though small amounts of IgG and IgM are also found in milk (Hanson and Johansson, 1970) . Antibody activity against other micro-organisms like polio virus, streptococci, and pneumococci has also been shown in the secretory IgA fraction of human milk (Hodes et al., 1964; Hanson and Johansson, 1970; Mouton et al., 1970) . The secretory IgA molecule is more resistant to pH changes and proteolytic enzymes than is serum IgA or other immunoglobulins (Tomasi and Bienenstock, 1968; Hanson and Brandtzaeg, 1972) , which may enable the secretory IgA antibodies of milk to function in the variable milieu of the gut. Some preliminary experiments have indicated, however, that a nucleotide dependent reductase isolated from liver can split secretory IgA . Similar enzymes are produced by microorganisms such as Esch. coli present in the gut (Moore, Reichard, and Thelander, 1964) , so it may be that such enzymes are able to attack the secretory IgA antibodies of milk.
In early colostrum as much as 20 to 40 mg/ml of IgA may be found (Amman and Stiehm, 1966; Hanson et al., 1971) . After the first 2 to 4 days there is a drop to values at the level of 1 mg/ml, but the increase in milk production may then compensate for the fall in immunoglobulin concentration. (An analogous situation was described by Schubert and Grunberg in a study of typhoid agglutinins (1949) .) The infant ingests sufficient amounts of these milk antibodies, mainly consisting of the stable secretory IgA, to permit their detection in the stools (Kenny et al., 1967; Michael et al., 1971; Gindrat et al., 1972) , where a correlation between the titres of such coproantibodies and a reduction in the number of coliform bacteria in the stool could be shown (Michael et al., 1971) . Cellular, enzymic, and protein components of breast milk. The antimicrobial activity of breast milk is not only mediated by antibodies. Milk also contains lymphoid cells which produce IgA and mediate cellular immunity, as well as neutrophils and macrophages with phagocytic activity (Smith and Goldman, 1968; Murillo and Goldman, 1970) . As many as 1000 to 4000 leucocytes/mm3 are regularly found in breast milk during the first 2 weeks after delivery (Mohr, Leu, and Mabry, 1970) . These cells may play a part in preventing infection in the maternal gland as well as in the infant's gastrointestinal tract.
Lysozyme (muramidase), which has antibacterial activity, is found in breast milk in amounts up to about 2 mg/ml (Hanson and Johansson, 1970) ; its possible influence on the faecal flora is suggested by the fact that it is found in significant amounts in the stools of breast-fed infants.
Human milk also contains large quantities of an iron-binding protein, lactoferrin, which is structurally different from transferrin (Hanson and Johansson, 1970) . Lactoferrin has a strong bacteriostatic effect on Esch. coli, as elegantly shown recently by Bullen, Rogers, and Leigh (1972) . Its bacteriostatic effect was potentiated by coli antibodies, but was abolished by saturation with iron, raising the important possibility that iron therapy may interfere with the function of lactoferrin. Cow's milk formulae contain much less lysozyme and lactoferrin than human milk.
A resistance factor against staphylococci is present in human milk (Gyorgy, 1971 ) and seems to consist of a fatty acid. Its protective role has only been shown in mice so far.
Chemical components of breast milk. The striking influence of breast milk on the faecal flora, with the suppression of Esch. coli and other Gram-negatives and promotion of such organisms as lactobacilli, may still not be mainly due to such factors as antibodies, lysozyme, and lactoferrin listed above, for the high lactose, low protein, and low phosphate content, together with the poor buffering capacity of breast milk may yet prove to be of equal or greater importance (Bullen and Willis, 1971) . In addition there is the bifidus factor belonging to a group of nitrogen-containing carbohydrates which promotes the growth of Lactobacillus bifidus, and this factor is more readily to be found in human than in cow's milk (Gyorgy, 1971) .
In summary, human milk contains many components which may both promote a 'normal' bacterial colonization of the gastrointestinal tract, and also suppress the invasiveness of certain pathogenic micro-organisms. These qualities of breast milk may be of major importance for the newborn infant's defence against infection, but further studies are needed to support this view.
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